CD247 and neoplasm: The first-generation CAR structure has only one intracellular CD3ζ signaling domain; although it can exert certain anti-tumor activity, it cannot transduce proliferative signals or induce the production of a large number of cytokines, which makes the downstream killing effect on tumors unsatisfactory.